|

Lepodisiran Clinical Trials

1 actively recruiting trial across 1 location

Also known as: LY3819469

Pipeline

Phase 1: 1

Top Sponsors

  • Eli Lilly and Company1

Indications

  • Liver Disease1
  • Liver Dysfunction1
  • Healthy1

Miami, Florida1 trial

A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function

Clinical Pharmacology of Miami

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.